We found that 2.5 mg/kg M3 treatment greatly reduced proinflammatory cytokine (IL6, IFNγ, TNFα, and IL-1β) mRNA expression in the lung 3 days after infection (Fig. 6c), which explains the high efficacy of M3 in protecting mice from lethal IAV infection. The gene discussed is IL1B; the disease is infection.